Collegium Pharmaceutical Inc (COLL)

Collegium Pharmaceutical Inc (COLL) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $701M; returns 1 day -2.3%, 1 week -1.0%, 1 year -35.4%.

Collegium Pharmaceutical is a specialty biopharmaceutical company focused on the commercialization of treatments for serious medical conditions, primarily chronic pain and neuropsychiatry. The company's business model transitioned significantly following the 2024 acquisition of Ironshore Therapeutics, diversifying its revenue stream from a pure-play pain management firm into the ADHD market.

Groups COLL belongs to

• Shrinking Share Count
• Buying Back Stock
• Pharmaceuticals
• Biopharmaceutical
• Commercial Stage
• Commercial Stage Biotech
• Pain Management
• Healthcare
• Neuroscience
• CNS Disorders
• Strategic Acquisitions

COLL financial model: income statement, cash flow and balance sheet